SCHEMBL18749812

SCHEMBL18749812

CNC(=O)Cc1ccccc1COc1ccc(C)cc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MRGPRX4 Q96LA9 1/20 0.50
▸ LMNA P02545 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ HTT P42858 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ CD274 Q9NZQ7 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MCL1 Q07820 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ PTGER1 P34995 1/20 0.40
▸ PTGER4 P35408 1/20 0.40
▸ PTGER3 P43115 1/20 0.40
▸ PTGER2 P43116 1/20 0.40
▸ FFAR1 O14842 2/20 0.39
▸ LPAR1 Q92633 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18749785 0.87 MRGPRX4 (0.48) MRGPRX4LMNAMAPTTDP1ALDH1A1
SCHEMBL18749777 0.87 MRGPRX4 (0.50) MRGPRX4LMNAMAPTHTTTDP1
SCHEMBL18749552 0.86 MRGPRX4 (0.47) MRGPRX4LMNAMAPTHTTTDP1
SCHEMBL18749695 0.86 MCL1 (0.43) MRGPRX4LMNAMAPTHTTTDP1
SCHEMBL18749790 0.86 PTGER1 (0.46) LMNAMAPTHTTTDP1L3MBTL1
SCHEMBL18749474 0.86 MRGPRX4 (0.51) MRGPRX4LMNAMAPTHTTTDP1
SCHEMBL18749558 0.86 MRGPRX4 (0.49) MRGPRX4LMNAMAPTCD274ALDH1A1
SCHEMBL18749814 0.86 MRGPRX4 (0.49) MRGPRX4LMNAMAPTHTTTDP1
SCHEMBL18515192 0.85 CD274 (0.46) LMNAHTTCD274ALDH1A1MAPK1
SCHEMBL18749696 0.85 MRGPRX4 (0.50) MRGPRX4MAPTHTTCD274L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9907307-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-06 — — US disclosed
US-9788547-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-17 — — US disclosed
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 — — US disclosed
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-0 MRGPRX4 959/4885LMNA 2808/4885MAPT 3329/4885
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-10 MRGPRX4 778/4885LMNA 3163/4885MAPT 2998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback